Enzaplatovir
Enzaplatovir (BTA-585) is an orally available fusion inhibitor with antiviral activity for the study of respiratory syncytial virus infections and coronavirus disease (COVID-19) infections.
Product Specifications
CAS Number
1323077-89-9
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
377.4
Molecular Formula
C20H19N5O3
Notes
Research use only, not for human use.
Receptor
RSV
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
K1436408 1.0 µg DNA
NMI sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 3)
Sign In for Pricing
View Details 
